Robyn Hickerson

Ten Bio Ltd. specializes in providing tailor-made solutions to help clients achieve progress in their skin research programs. The private company is based in Dundee, UK. The British company offers full-thickness human skin with dermal and epidermal layers, appendages, and minor skin cell populations. The company's human skin model, TenSkin™, responds like it would in vivo, delivering predictive results that contribute to a more efficient development process. The company was founded in 2019 by Robyn Hickerson and Michael Patrick Conneely, with Robyn Hickerson serving as CEO since then.

Ten Bio Ltd. specializes in providing tailor-made solutions to help clients achieve progress in their skin research programs. The private company is based in Dundee, UK. The British company offers full-thickness human skin with dermal and epidermal layers, appendages, and minor skin cell populations. The company's human skin model, TenSkin™, responds like it would in vivo, delivering predictive results that contribute to a more efficient development process. The company was founded in 2019 by Robyn Hickerson and Michael Patrick Conneely, with Robyn Hickerson serving as CEO since then.

Ten Bio Ltd. specializes in providing tailor-made solutions to help clients achieve progress in their skin research programs. The private company is based in Dundee, UK. The British company offers full-thickness human skin with dermal and epidermal layers, appendages, and minor skin cell populations. The company's human skin model, TenSkin™, responds like it would in vivo, delivering predictive results that contribute to a more efficient development process. The company was founded in 2019 by Robyn Hickerson and Michael Patrick Conneely, with Robyn Hickerson serving as CEO since then.

Ten Bio Ltd. specializes in providing tailor-made solutions to help clients achieve progress in their skin research programs. The private company is based in Dundee, UK. The British company offers full-thickness human skin with dermal and epidermal layers, appendages, and minor skin cell populations. The company's human skin model, TenSkin™, responds like it would in vivo, delivering predictive results that contribute to a more efficient development process. The company was founded in 2019 by Robyn Hickerson and Michael Patrick Conneely, with Robyn Hickerson serving as CEO since then.